In vivo and in vitro protective effects of shengmai injection against doxorubicin-induced cardiotoxicity
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceutical Biology"
DOI: 10.1080/13880209.2022.2046801
Abstract: Abstract Context Shengmai injection (SMI) has been used to treat heart failure. Objective This study determines the molecular mechanisms of SMI against cardiotoxicity caused by doxorubicin (DOX). Materials and methods In vivo, DOX (15 mg/kg) was… read more here.
Keywords: shengmai injection; smi fold; cardiotoxicity; smi ... See more keywords